You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-CD20

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

Recruiting
  • Urinary Bladder Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 27, 2023

COPD Trial in Lumezzane, Montescano, Tradate (LL group, L+UL group)

Recruiting
  • COPD
  • LL group
  • L+UL group
  • Lumezzane, Brescia, Italy
  • +2 more
Jan 23, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 22, 2023

Aboriginal Cultural Safety, Access to Interpreters, Health Literacy Trial in Darwin, Katherine, Nhulunbuy (Interventions to

Recruiting
  • Aboriginal Cultural Safety
  • +3 more
  • Interventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples
  • Darwin, Northern Territory, Australia
  • +3 more
Nov 17, 2022

Cancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis Trial in Lake Success (Ketamine Topical)

Not yet recruiting
  • Cancer of Head and Neck
  • +2 more
  • Ketamine Topical
  • Lake Success, New York
    Center for Advanced Medicine
Nov 1, 2022

Migraine, Headache Trial in Oak Lawn (Magnesium Sulfate, Metoclopramide 10mg, Prochlorperazine (Compazine) Injection)

Completed
  • Migraine
  • Headache
  • Magnesium Sulfate
  • +2 more
  • Oak Lawn, Illinois
    Advocate Christ Medical Center
Jul 26, 2023

Cervicogenic Headache Trial in Calgary (Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation)

Recruiting
  • Cervicogenic Headache
  • Transcranial Direct Current Stimulation
  • Sham Transcranial Direct Current Stimulation
  • Calgary, Alberta, Canada
    University of Calgary
Nov 30, 2022

Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
  • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
  • (no location specified)
Jun 6, 2023

HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

Recruiting
  • HIV Infection
  • N-803 (IL-15 Superagonist)
  • +2 more
  • Los Angeles, California
  • +11 more
Sep 22, 2022

Presbyopia Trial in United States (Pilocarpine HCl Ophthalmic Solution, Vehicle)

Completed
Has Results
  • Presbyopia
  • Pilocarpine HCl Ophthalmic Solution
  • Vehicle
  • Dothan, Alabama
  • +34 more
Nov 27, 2021

Anal Cancer Trial run by the NCI (Tempol, 5-Fluorouracil, Mitomycin-C)

Terminated
Has Results
  • Anal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 25, 2021

Recurrent Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Stage IV Trial in Spain (Nivolumab + Paclitaxel, Cetuximab +

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer Stage IV
  • Nivolumab + Paclitaxel
  • Cetuximab + Paclitaxel
  • Santander, Cantabria, Spain
  • +20 more
Aug 2, 2022

Osteoarthritis, Knee Trial in Chicago (Platelet-rich Plasma (PRP), Hyaluronic Acid)

Completed
Has Results
  • Osteoarthritis, Knee
  • Platelet-rich Plasma (PRP)
  • Hyaluronic Acid
  • Chicago, Illinois
    Rush University Medical Center
Sep 6, 2021

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Obesity Trial in Spokane (methylsulfonylmethane, )

Completed
  • Obesity
  • methylsulfonylmethane
  • placebo
  • Spokane, Washington
    Washington State University
Oct 4, 2021

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Triple Negative Breast Cancer
  • Datopotamab Deruxtecan (Dato-DXd)
  • Beijing, China
  • +27 more
Aug 11, 2022

Drug Resistant Epilepsy Trial in Sohag (Exogenous ketone ester)

Recruiting
  • Drug Resistant Epilepsy
  • Exogenous ketone ester
  • Sohag, Egypt
    Department of Pediatrics at Sohag University Hospital
Jan 18, 2023

Survivorship, Radiographic, and Functional Outcomes of Multihole

Terminated
  • Complications Arthroplasty
  • revision multihole acetabular cup
  • Cleveland, Ohio
    Cleveland Clinic
Jan 14, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Stamford, Connecticut
  • +4 more
Dec 2, 2022

COVID-19 Infection and Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • +2 more
    • Vienna, Austria
    • +7 more
    Aug 18, 2021

    Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

    Recruiting
    • Cancer of Unknown Primary Site
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Pancreatic Cancer Trial in Guangzhou (NanoKnife LEDC System)

    Completed
    • Pancreatic Cancer
    • NanoKnife LEDC System
    • Guangzhou, Guangdong, China
      FUDA Cancer Hospital
    Sep 1, 2021

    Abdominal Surgery Trial in Cleveland (Liposomal bupivacaine, Plain bupivacaine, Normal saline)

    Recruiting
    • Abdominal Surgery
    • Liposomal bupivacaine
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic
    Feb 9, 2022

    HIV Trial in United States (Cyclosporine)

    Completed
    • HIV Infections
    • San Francisco, California
    • +11 more
    Oct 27, 2021